ChiCTR-IOR-15005942
尚未开始
/
/
/
2015-02-03
/
/
Mild clinical Alzheimer’s disease
運動訓練與工作記憶訓練對減慢輕度阿氏痴呆症長者認知能力下降之隨機對比研究
運動訓練與工作記憶訓練對減慢輕度阿氏痴呆症長者認知能力下降之隨機對比研究
運動訓練與工作記憶訓練對減慢輕度阿氏痴呆症長者認知能力下降
随机平行对照
其它
Randomized
Single-blind
Health and Medical Research Fund
/
376
/
2015-02-14
1990-01-01
/
1. Subjects from 60 to 90 years old; 2. DSM-5 diagnosis of Major Neurocognitive Disorder due to AD (22), which would satisfy the criteria for significant cognitive decline in at least one of six areas of cognition (memory, perceptual-motor, complex attention, language, executive function and social cognition) and functional disturbance, with clinical or biological features indicative of AD; 3. CDR of 1 indicating mild dementia; and 4. Ambulatory with low risk of fall as assessed by the physiotherapist (co-A).;
请登录查看1. Past history of bipolar affective disorder or psychosis; 2. Physical frailty affecting attendance to training sessions; 3. Already attending regular cognitive training; 4. History of major neurological deficit including history of stroke, or traumatic brain injury; and 5. Significant communicative impairments.;
请登录查看Department of Psychiatry, The Chinese University of Hong Kong
/
Department of Psychiatry, The Chinese University of Hong Kong的其他临床试验
Department of Psychiatry, The Chinese University of Hong Kong的其他临床试验
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
- 定位連環透顱磁力剌激對認知障礙症患者抑鬱徵狀的療效研究
- 運動訓練與工作記憶訓練對減慢輕度阿氏痴呆症長者認知能力下降之隨機對比研究
- 個人化身心運動治療對抑鬱症及焦慮症之隨機對照臨床試驗效果研究
- A randomized controlled trial of leisure activity intervention on preservation of cognitive and everyday function in Chinese older adults with early cognitive decline
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-10
-
2026-09-09
-
2026-09-08
-
摩熵咨询 20 5
-
摩熵咨询 20 8
-
摩熵咨询 34 43
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-10
-
2026-09-10
-
2026-09-10
-
摩熵咨询 35 60
-
摩熵咨询 28 52
-
摩熵咨询 34 37
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29

